| Authors: |
Ferri-Borgogno S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center; SFerri@mdanderson.org., Stolley DL; Department of Hematopoietic Biology & Malignancies, The University of Texas MD Anderson Cancer Center., Gamal BT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center., Pacheco CD; Department of Hematopoietic Biology & Malignancies, The University of Texas MD Anderson Cancer Center., Veletic I; Department of Leukemia, The University of Texas MD Anderson Cancer Center., Basi A; Department of Leukemia, The University of Texas MD Anderson Cancer Center., Mak DH; Department of Hematopoietic Biology & Malignancies, The University of Texas MD Anderson Cancer Center., McAllister MK; Department of Hematopoietic Biology & Malignancies, The University of Texas MD Anderson Cancer Center., Lin AJ; Department of Hematopoietic Biology & Malignancies, The University of Texas MD Anderson Cancer Center., Gomez JA; Department of Leukemia, The University of Texas MD Anderson Cancer Center., Casasent AK; Department of Hematopoietic Biology & Malignancies, The University of Texas MD Anderson Cancer Center., Burks JK; Department of Hematopoietic Biology & Malignancies, The University of Texas MD Anderson Cancer Center; jburks@mdanderson.org. |
